181 related articles for article (PubMed ID: 38332655)
1. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.
Manning B; Arkell TR; Hayley AC; Downey LA
J Psychopharmacol; 2024 Mar; 38(3):247-257. PubMed ID: 38332655
[TBL] [Abstract][Full Text] [Related]
2. Cannabis effects on driving lateral control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
[TBL] [Abstract][Full Text] [Related]
3. Simulated driving performance among daily and occasional cannabis users.
Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
[TBL] [Abstract][Full Text] [Related]
4. Effect of CannEpil
Manning B; Hayley AC; Catchlove S; Shiferaw B; Stough C; Downey LA
J Psychopharmacol; 2023 May; 37(5):472-483. PubMed ID: 37129083
[TBL] [Abstract][Full Text] [Related]
5. The failings of
Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
[TBL] [Abstract][Full Text] [Related]
6. Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive.
Miller R; Brown T; Schmitt R; Gaffney G; Milavetz G
Accid Anal Prev; 2024 Feb; 195():107376. PubMed ID: 37984112
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
8. A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance.
Arkell TR; Manning B; Downey LA; Hayley AC
CNS Drugs; 2023 Nov; 37(11):981-992. PubMed ID: 37945917
[TBL] [Abstract][Full Text] [Related]
9. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests.
Fitzgerald RL; Umlauf A; Hubbard JA; Hoffman MA; Sobolesky PM; Ellis SE; Grelotti DJ; Suhandynata RT; Huestis MA; Grant I; Marcotte TD
Clin Chem; 2023 Jul; 69(7):724-733. PubMed ID: 37228223
[TBL] [Abstract][Full Text] [Related]
10. Cannabis effects on driving longitudinal control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
[TBL] [Abstract][Full Text] [Related]
11. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects.
Brands B; Mann RE; Wickens CM; Sproule B; Stoduto G; Sayer GS; Burston J; Pan JF; Matheson J; Stefan C; George TP; Huestis MA; Rehm J; Le Foll B
Drug Alcohol Depend; 2019 Dec; 205():107641. PubMed ID: 31678833
[TBL] [Abstract][Full Text] [Related]
12. Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.
Hartley S; Simon N; Cardozo B; Larabi IA; Alvarez JC
Front Public Health; 2023; 11():1234765. PubMed ID: 38074719
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and Driving in Older Adults.
Di Ciano P; Rajji TK; Hong L; Zhao S; Byrne P; Elzohairy Y; Brubacher JR; McGrath M; Brands B; Chen S; Wang W; Hasan OSM; Wickens CM; Kaduri P; Le Foll B
JAMA Netw Open; 2024 Jan; 7(1):e2352233. PubMed ID: 38236599
[TBL] [Abstract][Full Text] [Related]
14. On the impact of cannabis consumption on traffic safety: a driving simulator study with habitual cannabis consumers.
Tank A; Tietz T; Daldrup T; Schwender H; Hellen F; Ritz-Timme S; Hartung B
Int J Legal Med; 2019 Sep; 133(5):1411-1420. PubMed ID: 30701315
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
16. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses.
Schnakenberg Martin AM; Flynn LT; Sefik E; Luddy C; Cortes-Briones J; Skosnik PD; Pittman B; Ranganathan M; D'Souza DC
Psychopharmacology (Berl); 2023 Jun; 240(6):1235-1246. PubMed ID: 37045988
[TBL] [Abstract][Full Text] [Related]
18. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving.
Shahidi Zandi A; Comeau FJE; Mann RE; Di Ciano P; Arslan EP; Murphy T; Le Foll B; Wickens CM
Cannabis Cannabinoid Res; 2021 Dec; 6(6):537-547. PubMed ID: 34432541
[No Abstract] [Full Text] [Related]
20. [Effects of oral cannabis and dronabinol on driving capacity].
Giroud C; Augsburger M; Favrat B; Menetrey A; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mathieu S; Castella V; Hazekamp A; Mangin P
Ann Pharm Fr; 2006 May; 64(3):161-72. PubMed ID: 16710114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
